Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT06425588 Not yet recruiting - Healthy Clinical Trials

Craniofacial Dimensions as Determinants of the Fitted Performance of Common Face Masks (FACEFIT 2.0)

Start date: May 30, 2024
Phase: N/A
Study type: Interventional

This study examines the role of craniofacial dimensions and self-evaluation thereof in the protection afforded by masks commonly worn by the public as protection against aerosol contaminants. The effectiveness of instructions for self-evaluation of craniofacial dimensions will be tested against standard digital and manual craniometric methods. Approximately 500 (18-70 year old) subjects of any gender. After consenting to participate in the study, subjects will use a short self-assessment questionnaire to measure their craniofacial dimensions, and have their face measured using standard anthropological techniques and a 3D camera. They will then enter a chamber containing an atmosphere of aerosolized salt particles where the fitted filtering efficiency of 2 types of face masks will be measured briefly. Participation time is approximately 60 minutes.

NCT ID: NCT06424756 Not yet recruiting - Healthy Clinical Trials

Effects of an Antioxidant Supplement on Blood Vessel Health

Start date: July 1, 2024
Phase: Phase 2
Study type: Interventional

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide, and the non-Hispanic Black (NHB) population is disproportionately affected. Our research has previously demonstrated that oxidative stress may contribute to reduced vascular function in otherwise healthy NHB adults, potentially predisposing them to the development of hypertension and CVD. This study is designed to examine whether the mitochondria are an important source of oxidative stress-induced vascular dysfunction in healthy NHB adults.

NCT ID: NCT06423261 Active, not recruiting - Healthy Clinical Trials

Safety, Tolerability, Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects

Start date: August 24, 2023
Phase: Phase 1
Study type: Interventional

This trial is conducted in China. The purpose of this clinical trial is to evaluate the safety and tolerability, pharmacokinetic (PK) characteristics, and immunogenicity of single/multiple inhalation of different doses of GB002 recombinant peptide in healthy subjects.

NCT ID: NCT06420414 Completed - Healthy Clinical Trials

Physiological and Psychological Effects of Virtual Reality vs Traditional Exercise

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

This study aimed to explore the feasibility and effectiveness of immersive Virtual Reality (VR) as an alternative to traditional High-Intensity Interval Training (HIIT) by comparing physiological and psychological outcomes in physically active university students. The pilot randomised controlled trial utilised a parallel design involving two groups: one group performed HIIT using the Facebook Oculus Quest 2 VR headset with the "FitXR" fitness game, while the other undertook traditional HIIT training that mirrored the movements and actions of the VR game. The study's findings suggest that fully immersive VR provides a unique and potentially more enjoyable alternative to traditional HIIT, particularly because it may enhance motivation while still achieving health benefits. This pilot research study highlights VR's potential to reach high-flow states in exercise, where individuals become deeply absorbed and derive satisfaction from the activity. It also lays the groundwork for future studies involving larger sample sizes and clinical populations to further investigate the psychological and physiological impacts of VR-based exercise. In summary, this pilot randomised controlled trial found that immersive VR could be a feasible and effective alternative to traditional HIIT training, offering similar physiological benefits while enhancing exercise motivation and enjoyment. Further research is necessary to validate these preliminary results and extend them to diverse populations.

NCT ID: NCT06419660 Recruiting - Healthy Clinical Trials

A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood

Start date: May 21, 2024
Phase: Phase 1
Study type: Interventional

The main objective of this trial is to investigate the effect of the proton pump inhibitor esomeprazole on the pharmacokinetics of BI 3000202 in plasma.

NCT ID: NCT06419335 Not yet recruiting - Healthy Clinical Trials

Reducing Fatigue With CoQ10 Supplementation in Patients With Crohn's Disease Study

Start date: June 1, 2024
Phase: Early Phase 1
Study type: Interventional

This study includes an open label clinical trial comparing two doses of CoQ10 for 8 weeks to improve fatigue among patients with Crohn's disease and a prospective cohort study of healthy controls taking CoQ10 for 2 weeks. Additionally, among 15 participants who do not meet the fatigue threshold for the open label trial, the investigators will measure CoQ10 levels in blood and fasting urine, as well as complete the same data collection. Hypotheses 1. Fatigue will improve with CoQ10 and there will be a dose response with greater improvement with higher dose as measured by the Patient Reported Outcomes Measurement Information Systems Fatigue PROMIS Fatigue 7a instrument. 2. Fatigue will improve when measured with other fatigue scales in a similar dose dependent manner and that general and physical fatigue will improve more than mental fatigue. 3. CoQ10 will improve quality of life as measured with the short Inflammatory Bowel Disease Questionnaire (sIBDQ).

NCT ID: NCT06417645 Recruiting - Healthy Clinical Trials

Re-evaluation of the Effect Site Model of the PKPD Propofol Eleveld Model

Eleved PD
Start date: September 1, 2013
Phase: Phase 4
Study type: Interventional

in healthy patients undergoing elective surgery, after a very slow induction, using Eleveld's kinetics as a reference, after loss of consciousness (LOC) and intubation, proceed to infuse propofol until 1% burst suppression ratio is obtained. Then return to the LOC concentration. The BISindex predicted by the model and the real one will be evaluated. The evolution of spectral density frequencies over time will also be evaluated.

NCT ID: NCT06416787 Not yet recruiting - Healthy Clinical Trials

Safety and Tolerability of IBI355 in Healthy Volunteers

Start date: May 17, 2024
Phase: Phase 1
Study type: Interventional

This study aims to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of IBI355 in Healthy voluteers. This study also aims to evaluate the anti-Drug antibody after multiple ascending doses of IBI355 in Healthy voluteers.

NCT ID: NCT06416774 Completed - Healthy Clinical Trials

A Clinical Study of 68Ga-HX01 Injection for PET Imaging

Start date: December 29, 2022
Phase: Phase 1
Study type: Interventional

This is a single-center, open Phase I clinical study, consisting of two parts: a Phase Ia study in healthy adult subjects and a Phase Ib study in patients with malignant solid tumors.

NCT ID: NCT06415045 Recruiting - Healthy Clinical Trials

A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food

Start date: May 28, 2024
Phase: Phase 1
Study type: Interventional

The main objective is to investigate the effect of food on the pharmacokinetics of BI 1015550 Formulation C2.